Ground News

Don't Just Read the News, Understand It.

contemporarypediatrics.com image

News from contemporarypediatrics.com

See all of contemporarypediatrics.com news coverage in one place. Discover how contemporarypediatrics.com’s media bias informs their coverage and compare with thousands of other news outlets.

We’ve discovered 161 headlines written by contemporarypediatrics.com during the past 3 months.

contemporarypediatrics.com’s media bias is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

contemporarypediatrics.com’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about contemporarypediatrics.com

Where is contemporarypediatrics.com located?contemporarypediatrics.com's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top contemporarypediatrics.com News

US FDA approves Gilead's twice-yearly injection for HIV prevention

HIV · United States

US FDA approves Gilead's twice-yearly injection for HIV prevention

64% Center coverage: 262 sources

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among people given an injection every six months. See the Story

Pressure Builds on Kennedy’s Vaccine Panel Ahead of First Meeting

US Politics · United States

Pressure Builds on Kennedy’s Vaccine Panel Ahead of First Meeting

65% Center coverage: 97 sources

By Sarah Owermohle, Meg Tirrell, CNN (CNN) — Ahead of the first meeting of newly appointed vaccine advisers to the US Centers for Disease Control and Prevention, lawmakers are sharing fresh concerns about the panel’s membership and last-minute actions that could see Covid-19 and influenza vaccines thrown into question. Sen. Elizabeth Warren, a Massachusetts Democrat,See the Story

FDA Approves Once-Monthly Hereditary Angioedema Drug

FDA · United States

FDA Approves Once-Monthly Hereditary Angioedema Drug

51% Center coverage: 63 sources

Anti-factor XIIa biologic garadacimab (Andembry) got the FDA greenlight for use in preventing hereditary angioedema (HAE) attacks in adult and pediatric patients ages 12 years and older, CSL announced.See the Story

FDA Approves At-Home Belimumab Autoinjector for Pediatric Lupus Nephritis

Belimumab is now the first and only subcutaneous biologic therapy approved for at-home administration in pediatric lupus nephritis.FDA · United States See the Story

E-Cigarette and Cannabis Social Media Posts Pose Risks for Teens, Study Finds

100% Center coverage: 1 sources

Teens who see social media posts showing cannabis or e-cigarettes, including from friends and influencers, are more likely to later start using those substances or to report using them in the past month, according to surveys done by researchers at the Keck School of Medicine of USC.Influencers · Los Angeles See the Story

ACIP: New members meeting June 25-26; AAP liaisons not participating

The American Academy of Pediatrics will continue to hold its own childhood vaccine schedule, as it has since the 1930s.United States · United States Read Article

Study: School-based treatments stop cavity progression in NYC children

Silver diamine fluoride and atraumatic restorative treatment stopped most cavities in NYC children, showing school-based care can reduce decay.New York State · New York Read Article

Avalon 2025 Lab Trend Report: Genetic Testing Soars as Routine Testing Stabilizes

Surging demand for biomarkers and genetic diagnostics spotlights cost, access, and innovation challenges for health plansInnovation · United States See the Story

Upadacitinib Effective for Disease Clearance, Itch in Older Adults with Atopic Dermatitis

These data from RAD 2025 highlight upadacitinib’s efficacy in the phase 3 Measure Up 1 and 2 studies for older adults with atopic dermatitis.United States · United States See the Story

Caffeine proposed as a potential tool in reducing risk of SIDS

Caffeine may protect infants from SIDS by reducing oxygen drops, offering a potential new tool alongside safe sleep practices, a recent study suggests.Read Article

FDA Approves Merck’s Monoclonal Antibody Treatment for RSV in Infants

The U.S. Food and Drug Administration (FDA) has approve […] The post FDA Approves Merck’s Monoclonal Antibody Treatment for RSV in Infants first appeared on GeneOnline News. The post FDA Approves Merck’s Monoclonal Antibody Treatment for RSV in Infants appeared first on GeneOnline News.Merck · United States See the Story

Breaking News Topics Related to contemporarypediatrics.com